Evgeniya Karlovskaya, the Rector of Belgorod National Research University, presented the university’s results for 2024 at a meeting of the Council for the Support of Universities’ Development Programs.
This council, which includes participants from the Priority-2030 program, was chaired by the Minister of Science and Higher Education, Valery Falkov. The BelSU team, led by Rector Evgeniya Karlovskaya, included Vice-Rector for Strategic Development, Science, and Innovation, Elena Skripnikova, Professor Mikhail Korokin from the Research Institute of Pharmacology of Living Systems, and representatives from the university’s industrial partners: Alexander Kosopletkin, CEO of Pharmstandard-Leksredstva OJSC, and Sergey Masyuk, CEO of Artgen Biotech PJSC.
During her presentation on the achievements under the Priority-2030 program, Evgeniya Karlovskaya highlighted a significant shift in research and development focus toward projects with a higher level of technological readiness. This shift has notably increased industrial partners’ interest in long-term collaborations.
One key infrastructure project involves joint efforts with Pharmstandard Leksredstva LLC to create and conduct preclinical studies for a line of veterinary medicines. The company is currently constructing a new production line, while BelSU is responsible for creating products it will produce.
“Since the launch of the Priority-2030 program, the total number of scientific and educational projects that BelSU implements in collaboration with industrial partners, regional authorities, and both Russian and foreign educational organizations has doubled, reaching over 300 annually,” commented Rector Karlovskaya.
She also highlighted four product-oriented scientific projects aligned with national initiatives aimed at ensuring technological leadership. One such project is ATLAS, developed in partnership with Industrial Electronic Systems LLC. This automated measuring complex is the first of its kind in Russia, designed to record geometric parameters on railway tracks within mines. Following successful industrial tests, a prototype has been transferred to Yakovlevsky GOK for practical use. In a similar vein, KMAruda Kombinat JSC has commissioned further enhancements to the automated measuring complex, incorporating machine vision technology to monitor deformations in mine workings and analyse data using artificial intelligence. This development holds promise for applications in open-pit mining, metro construction, and across Russian railways. By 2026, BelSU plans to establish a serial production line for ATLAS automated measuring systems.
Additionally, researchers at BelSU are collaborating with Rusagro-Invest LLC to develop a self-propelled crop spraying drone for use in agriculture.
In partnership with TEKHNOINKOM LLC, the university is also working on an improved technology for producing hot briquetted iron as part of direct import substitution efforts.
Within the framework of the “Bioeconomics” national project, BelSU is undertaking a joint initiative with Yakovlevsky Mining and Processing Plant to develop methods for effectively using and mass-propagating economically valuable plants. This project aims to address production challenges faced by industrial and agricultural enterprises. Notably, BelSU has created a technology for micro-clonal propagation of plants that can eliminate up to 90% of contaminants in wastewater from settling ponds at the mining and processing plant.
The project titled “Development of Genetic Technologies in Plant Growing of Economically Valuable Crops Using Vitis Vinifera” is a key component of the national technological leadership initiative, “New Health Preservation Technologies.” In collaboration with Pharmstandard LLC, this project utilizes red grapes from a unique collection of northern varieties cultivated on the plantations of Belgorod National Research University. As a result, a technology has been developed for producing a fermented berry concentrate with a specified content of biologically active substances, leading to the creation of an experimental batch of the dietary supplement “Rezvitrin,” which boasts antioxidant, anti-inflammatory, and neuroprotective effects.
Overall, as Rector Karlovskaya highlighted, the research and development efforts have made a substantial contribution to the university’s consolidated budget.
“The main outcome of implementing the development program is the increased engagement of our team in transformative processes, as well as the university’s enhanced capacity to deliver breakthrough results that were previously unattainable,” concluded Evgeniya Karlovskaya.
<< Назад к списку |